Uncategorized Archives - Page 218 of 248

FridayDec 01, 2017 9:24 am

AppSwarm, Inc. (SWRM) Builds on Mobile Expertise in Crowded Marketplace

App revenue worldwide reaches record levels App downloads rise eight percent between 3Q 2016 and 3Q 2017 AppSwarm building on business app offerings with cannabis industry LOI As the growing number of app downloads and associated revenues continue to hit record levels, AppSwarm, Inc. (OTC: SWRM) is turning its expertise in the mobile gaming industry toward the task of helping smaller online game developers and business utility app makers as they negotiate the crowded app marketplace. AppSwarm uses its proprietary “Swarm” screening process to spot mobile apps with viral potential and help them get to market, where they can connect…

WednesdayNov 29, 2017 9:00 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Offers a Sweet Escape for Cannabis Users without Smoking or Sweeteners

Proprietary lipophilic enhancement technology boosts bioavailability of orally ingested cannabinoids and masks unpleasant taste Only company in the world to obtain a patent for improved oral or ingestible delivery of all cannabinoids, including both non-psychoactive and psychoactive Company generates revenue from out-licensing its technology The cannabis market is exploding globally as well as domestically, and Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has pioneered an enabling technology that enhances the body’s absorption of cannabinoids—an advancement from which many cannabis-related companies can profit. Lexaria’s proprietary lipophilic enhancement technology has demonstrated the ability to boost the bioavailability of all orally ingested cannabinoids.…

WednesdayNov 29, 2017 9:00 am

India Globalization Capital, Inc. (NYSE: IGC) Enters MOU for Distribution in Germany, Plans to Commercialize Liquid Formulation of Hyalolex

IGC is scheduled to market a liquid formulation of its drug, IGC-AD1 (Hyalolex), in 2018; company is eyeing markets in Germany, Canada and U.S. states where licensed medical cannabis has been legalized IGC is exclusive licensee of a U.S. patent filing for possible THC-based Alzheimer's disease (AD) therapy, which, if approved, could give it a huge advantage in competition for share of global drug market for AD Alzheimer’s Association: Some five million Americans have AD or some form of dementia, and $259 billion is being spent on treatments in 2017 — a number that could skyrocket to $1.1 trillion by…

WednesdayNov 29, 2017 9:00 am

Companies Offer Intriguing Investment Opportunities as Bitcoin Continues Smashing Records

CannabisNewsWire Editorial Coverage: In just two months’ time, rising superstar bitcoin has almost doubled its trading record. This leading cryptocurrency, which has continued to shatter its own records again and again this year, broke the $5,000 ceiling in September and is now closing in on $10,000 just under two months later. Bitcoin is definitely a hot ticket among investors right now, but not all investors want to put money into this cryptocurrency directly. Various enterprising companies emerging within the marketplace are providing promising ancillary investment options for those seeking to cash in on bitcoin’s rising star without investing directly in…

TuesdayNov 28, 2017 11:05 am

Global Payout, Inc. (GOHE) Guided by Vision and Acumen

GOHE at vanguard of explosive FinTech industry growth Guided by nearly 100 years of executive talent and experience Proprietary state-of-the art systems position GOHE for significant footprint Founded in 2009 with a focus on prepaid debit cards and electronic wallets, Global Payout, Inc. (OTC: GOHE) has deftly evolved into a full service payment platform that delivers complete customizable payment solutions for almost any entity engaged in domestic or international financial transactions. A leader in the booming FinTech industry, Global Payout has distinguished itself as a premier global provider of payment and disbursement services to unbanked, underbanked and bank adverse customers.…

MondayNov 27, 2017 12:22 pm

Medical Cannabis Payment Solutions (REFG) Integrates Cryptocurrency Payment Options

The rapid growth of the legal cannabis industry has increased the need for tailored and comprehensive payment solutions for dispensaries and other retailers in the field. Medical Cannabis Payment Solutions partnered up with First Bitcoin Capital Corporation to enable cryptocurrency payments. The company has also launched its specialized digital payment platform for dispensaries that ensures full compliance and delivers full-spectrum merchant processing services. Medical Cannabis Payment Solutions (OTC: REFG) announced that it will integrate First Bitcoin cryptocurrency ("$Weed") with its StateSourced medical cannabis payment gateway service. The announcement came in November, following a partnership agreement between Medical Cannabis Payment Solutions…

MondayNov 27, 2017 11:45 am

ChineseInvestors.com, Inc. (CIIX) OptHemp Line Achieves a Big Hit with Product Launch

OptHemp Product Line successfully launched on Amazon and Alibaba CBD Magic Hemp Series generated 40,000 views and the purchase of over 91 units just minutes into launch CIIX offering is an innovative product line in what CBD Biotechnology believes to be an untapped segment of China’s booming skin care market ChineseInvestors.com, Inc. (OTCQB: CIIX), in partnership with its foreign enterprise, CBD Biotechnology Co. Ltd. and through its subsidiary ChineseHempOil.com, Inc. has successfully launched its OptHemp product Line via a Top 100 platinum level seller on Amazon.com (NASDAQ: AMZN) and on China’s largest e-commerce retailer Alibaba. During its debut broadcast of…

WednesdayNov 22, 2017 8:30 am

Marijuana Company of America, Inc. (MCOA) Offers Promising Portfolio in Cannabis and Hemp

Global cannabis market to hit $31 billion by 2021 Diverse portfolio positioned along the cannabis and hemp value chains Completed financing for 30,000 sq. ft. greenhouse cultivation facility Wholly-owned subsidiary, HempSMART™, currently has CBD-based wellness products available for sale A new report from market analyst the Brightfield Group, featured in Forbes (http://cnw.fm/XV6oq), estimates that global sales of cannabis will climb to $31.4 billion by 2021. The U.S., which “currently drives 90 percent of global cannabis sales,” will dominate this international business. In turn, a large share of the U.S. cannabis market will undoubtedly go to one of the six biggest…

TuesdayNov 21, 2017 10:15 am

Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is “One to Watch”

Management, R&D team boasts decades of industry leadership Pipeline includes therapies targeting chronic pain, nausea, inflammation, muscle spasms, epilepsy and Post Traumatic Stress Disorder Unique result-driven strategy strongly positions Veritas in the medical marijuana industry Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is an emerging pharmaceutical and IP development company publicly traded in Canada, the United States and Germany. Through its recently acquired 80 percent stake in Cannevert Therapeutics Ltd., also known as Veritas’ R&D arm, the company is clinically profiling various marijuana cultivars to pharmacologically connect unique strains with specific disease conditions. Veritas Pharma’s goal is to perform clinical…

TuesdayNov 21, 2017 8:30 am

Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products

Announces formation of new Canadian subsidiary Ovation Science Inc. Agreement forged with Lighthouse Strategies, LLC, regarding exclusive use of patented topical and transdermal formulations in select U.S. markets Licensing agreement recently made with Canopy Growth Corp. for exclusive rights in Canada Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC (http://cnw.fm/6HjR4). The agreement, made through Ovation, stipulates that Lighthouse will have exclusive use of the company’s patented topical and transdermal formulations for select…